14.182 articles found

Neuroinflammatory and Motor Alterations in LRRK2*G2019S Transgenic Mice Without Enhanced Vulnerability to Aging or Chronic MPTP-Induced Nigrostriatal Neurodegeneration.

García-Swinburn R, Morón-Márquez L, Conde-Naranjo C, García-Roldán E, Espadas I, Rodríguez-Gil A, Ramírez-Lorca R, Villadiego J, Toledo-Aral JJ.

J Neurochem · 2026-09-01

DOI: 10.1111/jnc.70547PMID: 42713709

TUBA4A Pathogenic Variant Manifesting With Adulthood-Onset Genetic Myasthenic Syndrome, Myopathy, and Infertility.

Milone M, Nicolau S, Niu Z, Liewluck T, Sorenson EJ, Shen XM, Harper CM, Litchy WJ.

Eur J Neurol · 2026-09-01

DOI: 10.1111/ene.70753PMID: 42725680

mTOR and STING Modulation Restores Hydrolase Activities and Decreases Alpha-Synuclein Pathology in the Cells from the Patients with GBA1-Associated Parkinson's Disease.

Usenko TS, Bezrukova AI, Basharova KS, Grigor'eva EV, Pavlova SV, Baydakova GV, Miliukhina IV, Zakharova EY, Pchelina SN.

Biochemistry (Mosc) · 2026-09-01

DOI: 10.1134/s0006297926601644PMID: 42830104

DNA Methylation of the <i>SNCA</i> Intron 1 and Alpha-Synuclein Expression in the CD45+ Blood Cells in Parkinson's Disease.

Lavrinova AO, Litusova EM, Dmitriev AA, Melnikova NV, Pidyurchina VN, Kulabukhova DG, Syreva OV, Miliukhina IV, Timofeeva AA, Berkovich OA, Pchelina SN, Emelyanov AK.

Biochemistry (Mosc) · 2026-09-01

DOI: 10.1134/s0006297926601735PMID: 42830106

Parkinson's disease-associated LRRK2 risk variant, G2385R, enhances Rab substrate phosphorylation and impairs neuronal integrity.

Nguyen APT, Moser R, Bryant N, Cunningham LA, Worden EJ, Moore DJ.

Hum Mol Genet · 2026-09-01

DOI: 10.1093/hmg/ddag103PMID: 42837290

α-Synuclein Binding Alkaloids from the Australian Bryozoan Amathia tricornis.

Ferretti F, Hayton JB, Mellick GD, Carroll AR.

J Nat Prod · 2026-09-01

DOI: 10.1021/acs.jnatprod.6c00883PMID: 42913388

How a Single-Chain Polystyrene Nanoparticle Dictates α-Synuclein Adsorption and Intramolecular β-Sheet Nucleation.

Wang K, Gong S, Sheng Y, Shen L.

Langmuir · 2026-09-01

DOI: 10.1021/acs.langmuir.6c03846PMID: 42918022

Genetic Screening of Colombian Patients With Early-Onset Parkinson Disease.

Franz TM, Gavrielatos M, Wijaya Y, Beasley AI, Kim-Hellmuth S, Strongosky AJ, Moreno-López CL, Ross OA, Wszolek ZK, Cerquera-Cleves C.

Neurol Genet · 2026-09-01

DOI: 10.1212/nxg.0000000000200427PMID: 42699711

Schwann cell-associated early α-synuclein aggregation in skin biopsies of multiple system atrophy patients

Basellini MJ, Calogero AM, Mazzetti S, Cagni E, Calandrella D, Isaias IU, Cappelletti G, Pezzoli G, Contaldi E.

· 2026-08-31

DOI: 10.21203/rs.3.rs-10762754/v1

The <i>LRRK2</i> R1441G+M1646T haplotype is associated with slower motor symptom progression in Parkinson’s disease

Schumacher JG, Zhang X, Wang J, Chen X.

· 2026-08-31

DOI: 10.64898/2026.08.26.26361428

Vascularizing neurospheroids to probe vascular contributions to α-synuclein pathology in Parkinson’s disease

Alim A, Lwin S, Saha P, Baek Y, Lee M, Paek J.

· 2026-08-31

DOI: 10.64898/2026.08.28.747883

The LRRK2 R1441G+M1646T haplotype is associated with slower motor symptom progression in Parkinson’s disease

Check source for author details

medRxiv · 2026-08-31